Well, the lines are drawn on the battlefield that has become Cree (CREE) . The company announces earnings on Tuesday after the close, and I can't recall seeing so much diversity in outlooks. Simply put, somebody is gonna be wrong ... very wrong. I don't have a dog in this fight (i.e., no position), but I do believe the fight is fascinating. Here is the breakdown. The BearsLet's face it -- this power LED technology company is almost universally hated, with 31.7% of the float short. That yields a short-interest ratio of 9.4 -- that is, almost 10 days of trading for all the shorts to cover. Eric Ross, director of research at Canaccord Adams, has been on CNBC recently, pounding on the stock as his firm's favorite short idea, saying the company has low-quality products and antiquated technology. He believes the stock will plummet this year; his price target sits way down at $16 (Cree closed yesterday at $26.31). Jed Dorsheimer is the Canaccord analyst who covers Cree. His model calls for $109 million in revenue; he has been telling investors that his numbers are likely a bit generous and that $105 million is more likely. He also has been advising clients that management will guide lower. Dorsheimer recently got kudos from Barron's for his sell rating on Cree. Since everybody seems to hate Cree anyway, I'm not really sure that Dorsheimer was blazing any new trails. Ah, but I digress. Another notable bear is Hans Mosesmann at Raymond James, who also projects that Cree will miss its quarter; Mosesmann has a price target of $8. Chris Versace, who writes for RealMoney, has been covering the Cree story for the past several months, particularly from the mobile-phone angle. He wrote another bearish piece on Cree last week, noting that Cree faces an uphill battle because of shrinking margins on the LEDs used in handset backlighting. Versace also notes that handset backlighting has been one of CREE's "key niches" in the mobile device industry.The BullOn the other side of the line stands American Technology Research. AmTech is an independent research firm that has been the lone wolf on Cree. Andrew Huang, the AmTech analyst covering Cree, has a price target of $55. Richard Prati, CEO of AmTech, believes that Cree will make its earnings and will probably guide higher. Further, he says that despite what Versace claims, Cree does not stand to lose in the handset backlighting business because it is such a small part of Cree's business. Additionally, Prati says that Lumileds -- a subsidiary of Philips Electronics (PHG) -- is having quality-control issues and will not be shipping its power LEDs, which compete with Cree's XLamp. Going forward, Lumileds' loss will be Cree's gain. Given the Lumileds misstep, timing could not be more fortuitous for Cree, which recently announced plans to expand capacity of its White XLamp LEDs. Prati believes that by the June quarter of this year, Cree will have triple the capacity than the prior year of these high-power LEDs used for lighting. Further, Prati believes that the current problems experienced by Lumileds illustrate that power LED technology is not as simple as some people believe, and that the intricacies of the technology will prevent the commoditization of power LED technology by Asian competitors, which is a concern that Versace expressed in his recent piece.My TakeNow, I wouldn't know an LED from a knobby knee ... but I have looked at a chart or two in my day.TSM Is a Stable Buoy in a Rocky Sea Quick Pick: CREE Feels Pricing Pressure RFMD's Puzzling Warning
At the time of publication, Fitzpatrick had no positions in the stocks mentioned, though positions may change at any time.
Dan Fitzpatrick is the publisher of StockMarketMentor.com, an advisory newsletter and educational forum dedicated to teaching effective risk management and trading methodologies to aspiring traders and investors. He is a former hedge fund manager and a member of the Market Technicians Association, and he now trades from his home in San Diego, Calif. While Fitzpatrick holds various securities licenses, he does not give recommendations to buy or sell stocks. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. He appreciates your feedback; click here to send him an email.
Read our conflicts and disclosure policy. |
|
Terms of Use | Privacy Policy
© 1996- TheStreet.com, Inc. All rights reserved. |